Firm’s €119m investment brings jobs hope to North

A Northern Ireland pharmaceutical company today announced an investment of £83m (€119m) which could create almost 300 new jobs.

Firm’s €119m investment brings jobs hope to North
Tue, 30 Oct, 2007 - 10:32

A Northern Ireland pharmaceutical company today announced an investment of £83m (€119m) which could create almost 300 new jobs.

Norbrook makes veterinary pharmaceutical products at its Newry, Co Down, plant and exports them around the world.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

Benefit image

Limited offer valid for new and returning customers. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €12/month. Ts&Cs apply.

WhatsApp logo

Irish Examiner’s WhatsApp channel

More in this section

Weight-loss drugmaker says Irish plants will 'continue to play significant role' Weight-loss drugmaker says Irish plants will 'continue to play significant role'
Strike action by school secretaries and caretakers suspended for fresh WRC talks Strike action by school secretaries and caretakers suspended for fresh WRC talks
16/9/2014 Civilianise Immigration Checks Structure Security Gardaí deport 42 Brazilian nationals in major immigration operation
CourtsHeathrowPlace: NorthPlace: Northern IrelandPlace: NewryPlace: Co DownPlace: Co DerryPlace: USPlace: MalaysiaPlace: MonaghanPlace: LimavadyPerson: Economy MinisterPerson: Nigel DoddsPerson: DoddsPerson: NorbrookPerson: Executive ChairmanPerson: Lord BallyedmondOrganisation: NorbrookOrganisation: SeagateOrganisation: Invest NI
Father Ted co-creator Graham Linehan has spoken about his arrest (Jonathan Brady/PA)

Graham Linehan says he may never come back to Britain after arrest

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited